Parallax Volatility Advisers’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-38,800
Closed -$10.8M 3292
2020
Q3
$10.8M Buy
38,800
+8,500
+28% +$2.45M 0.01% 961
2020
Q2
$7.31M Buy
30,300
+8,300
+38% +$1.67M 0.01% 922
2020
Q1
$3.2M Buy
+22,000
New +$3.65M ﹤0.01% 1049
2019
Q2
Sell
-43,900
Closed -$12.5M 4015
2019
Q1
$12.5M Buy
+43,900
New +$14.6M 0.01% 419
2018
Q3
Sell
-10,400
Closed -$4.25M 3844
2018
Q2
$4.25M Buy
+10,400
New +$3.77M 0.01% 668

Other funds holding ABMD

Parallax Volatility Advisers's ABMD Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 3,601 shares — an estimated $998K sold.

Parallax Volatility Advisers first reported a position in ABMD in Q2 2018 and held it in 7 quarters. The position peaked at $5.09M in Q1 2019. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Parallax Volatility Advisers reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 3,601 Abiomed Inc shares in Q4 2020, an estimated $998K.
  • Parallax Volatility Advisers first reported a position in Abiomed Inc in Q2 2018 and held it in 7 quarters.
  • Parallax Volatility Advisers's Abiomed Inc position peaked at $5.09M in Q1 2019.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.